Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

19:55 EDT 19th September 2014 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 7,600+

Wednesday 17th September 2014

Language evolution: Quicker on the uptake

(Ludwig-Maximilians-Universität München) Defects in the gene FOXP2 result in a severe speech disorder. As LMU researchers now show, when the functional version of the human gene is introduced into mice, it facilitates learning, and alters neuronal ...

University of Kentucky research explores STXBP5 gene and its role in blood clotting

(University of Kentucky) Two independent groups of researchers led by Sidney Whiteheart, PhD, of the University of Kentucky, and Charles Lowenstein, MD, of the University of Rochester, have published important studies exploring the role that a gene c...

World breakthrough: A new molecule allows for an increase in stem cell transplants

(University of Montreal) Investigators from the Institute for Research in Immunology and Cancer at the Universite de Montreal have just published, in the prestigious magazine Science, the announcement of the discovery of a new molecule, the first of ...

Research milestone in CCHF virus could help identify new treatments

(Texas Biomedical Research Institute) New research into the Crimean-Congo hemorrhagic fever virus (CCHFV), a tick-borne virus which causes a severe hemorrhagic disease in humans similar to that caused by Ebolavirus, has identified new cellular factor...

Taiwan’s ITRI Expands To Biomedical Field, Looks For Japan Cooperation

With aggressive investment by the Taiwanese government in recent years, the Taiwan Industrial Technology Research Institute is showing results in the discovery of new regenerative medicine and biomedical drugs.

Transvaginal Mesh Lawsuit News: New Order in C.R. Bard MDL Sets Schedule of Conferences for September to December, the Rottenstein Law Group LLP Reports

United States Magistrate Judge Cheryl Eifert filed an order on September 15 in the multidistrict litigation (MDL) consolidating federal mesh lawsuits against C.R. Bard (In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation; Case 2:10-md-02187, U.S. District Court for the Southern District of West Virginia, Charleston Division) establishing a schedule of discovery conferences. ...

PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors

INCLINE VILLAGE, Nev., Sept. 17, 2014 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) was orally notified by its independent registered accounting firm, Ernst & Young LLP ("EY") that it was resigning effective September 11, 2014. The resignation was confirmed in a letter delivered to the Company on September 15, 2014 and reported in PDL's Form 8-K filed on September 16, 2014....

In Silico Drug Discovery Conference Announces Speakers and Topics

RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2014 /PRNewswire/ -- The In Silico Drug Discovery Conference today announced speakers and presentation topics that will be featured at the conference, which takes place at North Carolina Biotechnology Center's Hamner Conference Center on December 3 and 4, 2014. Researchers, students, drug developers, business development professionals, and biotechnology...

Novel mechanism involved in memory discovered

The discovery of a novel mechanism in the brain involved in the formation of memory and learning has been made by scientists. The discovery could have therapeutic ramifications for conditions including dementia, age-related memory loss or even post-t...

New non-invasive technique could revolutionize the imaging of metastatic cancer

Bioluminescence, nanoparticles, gene manipulation – these sound like the ideas of a science fiction writer, but, in fact, they are components of an exciting new approach to imaging local and metastatic tumors. In preclinical animal models of metast...

CORRECTING and REPLACING EMD Serono and Sutro Biopharma to Partner on Development of Antibody Drug Conjugates

EMD Serono to enhance its access to antibody drug conjugate technologies and to expand its oncology pipeline Sutro’s Xpress CF and Xpress CF+ platforms to be utilized to develop antibody drug conjugates for multiple undisclosed targets Sixth paragraph, second sentence of release should read: Sutro is also eligible t...

Dimension Therapeutics appoints Annalisa Jenkins as chief executive

Dimension Therapeutics, a US gene therapy company focused on rare diseases, has appointed Annalisa Jenkins as chief executive, who succeeds interim chief executive Thomas Beck.

Curie-Cancer, Inventiva partners in epigenetics for cancer

Curie-Cancer, the body responsible for Institut Curie’s industry partnership activities, and Inventiva, a French drug discovery company focusing on therapeutic approaches involving transcription factors and epigenetic targets, have launched the Epi...

Bioniche Life Sciences Receives Coverage as Highly Undervalued Biopharmaceutical

NEW YORK, NY -- (Marketwired) -- 09/17/14 -- Bioniche Life Sciences, Inc. (PINKSHEETS: BNHLF) (TSX: BNC), a clinical stage Canadian biopharmaceutical company focused on the discovery, development,...

Parent Project Muscular Dystrophy Names Seattle Children's Hospital Certified Duchenne Care Center

HACKENSACK, N.J., Sept. 17, 2014 /PRNewswire-USNewswire/ -- Seattle Children's Hospital was named a Certified Duchenne Care Center by Parent Project Muscular Dystrophy (PPMD), the leading advocacy organization working to end Duchenne muscular dystrophy (Duchenne). Seattle Children's is the fourth center to be certified by PPMD, recognizing the hospital's dedication to improving care for people liv...

Clinical utility gene card for: Aarskog–Scott Syndrome (faciogenital dysplasia)

The dystrophin gene and cognitive function in the general population

Asuragen’s Xpansion Interpreter® Test Study of 1,040 Transmissions of Fragile X Alleles Reveals Personalized Risks for Expansion from Parent to Child

Asuragen, Inc., announced today a collaborative publication with scientists at the New York Institute for Basic Research in Developmental Disabilities that describes the most comprehensive study to date examining the relationship between AGG sequence interruptions and the risk of triplet repeat expansion in the fragile X gene, FMR1. The publication, ...

Researchers use iPS cells to show statin effects on diseased bone

Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at the fetal stage and is caused by genetic mutations. A mutation in the gene encoding fibroblast growth factor re...

EMD Serono and Sutro Biopharma to Partner on Development of Antibody Drug Conjugates

EMD Serono to enhance its access to antibody drug conjugate technologies and to expand its oncology pipeline Sutro’s Xpress CF and Xpress CF+ platforms to be utilized to develop antibody drug conjugates for multiple undisclosed targets EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Sutro Bioph...

KineMed to Showcase Advances in Dynamic Proteomic Markers of Neurodegenerative Disease at the 8th Annual Neurodegenerative Conditions Research & Development Conference

KineMed, Inc. (www.kinemed.com) announced today that Dr. Patrizia Fanara, Vice President of Neuroscience at KineMed, will give a presentation titled “Translatable Dynamic Biomarkers: The Future of Biomarkers in Neurodegenerative Diseases” at the 8th Annual Neurodegenerative Conditions Research & Development Conference

Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role

Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study

MUMBAI, India, September 17, 2014 /PRNewswire/ -- Glenmark's first in class TRPA1 antagonist, GRC 17536, has shown positive data in a Phase 2a proof of concept study in patients with painful diabetic neuropathy Glenmark Pharmaceuticals today announced that its first in class Transient Receptor Potential Ankyrin 1 (TRPA1) antagonist, GRC 17536 has shown positive data in a Phase 2a double blin...

An improved ARS2‐derived nuclear reporter enhances the efficiency and ease of genetic engineering in Chlamydomonas

The model alga Chlamydomonas reinhardtii has been used to pioneer genetic engineering techniques for high‐value protein and biofuel production from algae. To date, most studies of transgenic Chlamydomonas have utilized the chloroplast genome due to...

Researchers Discover How Bacteria Resist Antibiotics in Hospitals

By Steven Reinberg HealthDay Reporter WEDNESDAY, Sept. 17, 2014 (HealthDay News) -- Scientists have uncovered a key factor to explain why antibiotic-resistant bacteria can thrive in a hospital setting. Tiny circles of DNA called plasmids a...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks